Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 188,900
-10,300 (-5.17%)
Oct 26, 2026, 3:30 PM KST
Sam Chun Dang Pharm. Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 259,900 | 231,805 | 210,924 | 192,669 | 177,335 | 167,275 |
Revenue Growth | 20.83% | 9.90% | 9.47% | 8.65% | 6.01% | 0.25% |
Gross Profit Gross Profit Growth | 122,727 | 109,091 | 99,285 | 96,605 | 89,630 | 82,835 |
Operating Income Operating Income Growth | 17,705 | 8,325 | 2,563 | 9,560 | 12,569 | -15,289 |
Net Income Net Income Growth | 17,782 | 5,262 | -10,916 | -10,383 | 5,838 | -16,555 |
Earnings Per Share EPS Growth | 762.18 | 226.00 | -474.29 | -463.03 | 264.52 | -750.19 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 216,566 | 202,990 | 198,780 | 183,179 | 166,840 | 161,190 |
Overseas Overseas Growth | 43,334 | 28,815 | 12,144 | 9,490 | 10,496 | 5,844 |
Total Total Growth | 259,900 | 231,805 | 210,924 | 192,669 | 177,335 | 167,034 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 102,532 | 129,058 | 141,917 | 92,744 | 86,248 | 102,025 |
Total Debt Total Debt Growth | 51,990 | 69,831 | 49,941 | 53,625 | 76,590 | 51,541 |
Net Cash (Debt) Net Cash Growth | 50,542 | 59,227 | 91,975 | 39,119 | 9,658 | 50,484 |
Net Cash Growth | -6.64% | -35.61% | 135.12% | 305.04% | -80.87% | -32.59% |
Net Cash Per Share Net Cash Per Share Growth | 2167.03 | 2546.56 | 3996.21 | 1718.95 | 437.65 | 2287.64 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 26,082 | 9,793 | 21,771 | 23,428 | 13,279 | -7,707 |
Capital Expenditures CapEx Growth | -56,663 | -46,146 | -17,022 | -6,766 | -16,531 | -14,882 |
Free Cash Flow Free Cash Flow Growth | -30,581 | -36,353 | 4,748 | 16,662 | -3,252 | -22,589 |
Free Cash Flow Growth | - | - | -71.50% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.22% | 47.06% | 47.07% | 50.14% | 50.54% | 49.52% |
Operating Margin | 6.81% | 3.59% | 1.21% | 4.96% | 7.09% | -9.14% |
Pretax Margin | 11.42% | 5.40% | 5.23% | -2.36% | 5.03% | -11.69% |
Profit Margin | 6.84% | 2.27% | -5.17% | -5.39% | 3.29% | -9.90% |
FCF Margin | -11.77% | -15.68% | 2.25% | 8.65% | -1.83% | -13.50% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 50.000 | 50.000 |
Dividend Per Share Growth | -75.00% | - |
Dividend Yield | 0.03% | 0.02% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 247.84 | 1027.68 | - | - | 165.58 | - |
Forward PE | - | 111.99 | 111.99 | 111.99 | 111.99 | 111.99 |
P/FCF Ratio | - | - | 727.36 | 105.58 | - | - |
PS Ratio | 17.01 | 23.33 | 16.37 | 9.13 | 5.45 | 5.72 |